84.15
Edwards Lifesciences Corp 주식(EW)의 최신 뉴스
Edwards Lifesciences (NYSE:EW) Given New $90.00 Price Target at Truist Financial - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Bank of New York Mellon Corp - MarketBeat
Wellington Shields Capital Management LLC Sells 5,700 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
EPO and UPC align in decision to uphold Edwards Lifesciences’ heart valve patent - JUVE Patent
36,530 Shares in Edwards Lifesciences Corporation $EW Purchased by Burney Co. - MarketBeat
What is the fair value of Edwards Lifesciences Corporation stock nowMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Envestnet Asset Management Inc. Has $26.61 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Truist Securities Maintains Edwards Lifesciences (EW) Rating, Ra - GuruFocus
Will Edwards Lifesciences Corporation (EWL) stock test record highs in 2025 - newser.com
Bernstein Adjusts Price Target on Edwards Lifesciences to $90 From $85 - MarketScreener
Is Edwards Lifesciences Corporation (EWL) stock positioned for secular growth2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Bernstein raises Edwards Lifesciences stock price target to $90 on TAVR growth - Investing.com
Canaccord Genuity raises Edwards Lifesciences stock price target on solid Q3 - Investing.com
Raymond James upgrades Edwards Lifesciences stock rating to Outperform By Investing.com - Investing.com Canada
Machina Capital S.A.S. Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Welch & Forbes LLC - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Telos Capital Management Inc. - MarketBeat
South Dakota Investment Council Has $13.38 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Can Edwards Lifesciences Corporation stock sustain institutional interestInsider Selling & Weekly High Return Stock Opportunities - newser.com
Will Edwards Lifesciences Corporation stock outperform foreign stocksJuly 2025 Highlights & Fast Entry High Yield Tips - newser.com
Raymond James upgrades Edwards Lifesciences stock rating to Outperform - Investing.com
How Edwards Lifesciences Corporation stock reacts to new regulations2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Can Edwards Lifesciences Corporation stock survive global slowdownMarket Performance Recap & Consistent Profit Alerts - newser.com
Strs Ohio Grows Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Amalgamated Bank Has $8.86 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation stock trend forecast2025 Market Overview & Long-Term Growth Stock Strategies - newser.com
Edwards Lifesciences Corporation (NYSE:EW) Q3 2025 Earnings Call Transcript - Insider Monkey
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences' (EW) Overweight Rating Reaffirmed at Piper Sandler - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00 at Royal Bank Of Canada - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00 - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $92.00 - MarketBeat
Mccarter Private Wealth Services LLC Reduces Position in Edwards Lifesciences Corporation $EW - MarketBeat
Lockheed Martin Investment Management Co. Has $4.34 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Fisher Funds Management LTD Has $74.16 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Using data models to predict Edwards Lifesciences Corporation stock movementWeekly Trend Summary & Risk Controlled Stock Pick Alerts - newser.com
Spire Wealth Management Raises Position in Edwards Lifesciences Corporation $EW - MarketBeat
Quantitative breakdown of Edwards Lifesciences Corporation recent moveMarket Performance Report & Weekly Sector Rotation Insights - newser.com
Edwards Lifesciences Topped Estimates As Demand For Heart Devices Rose - Finimize
Edwards Lifesciences Reports Strong Earnings and Growth - TipRanks
Edwards Lifesciences (NYSE:EW) Updates Q4 2025 Earnings Guidance - MarketBeat
Edwards Lifesciences (NYSE:EW) Announces Quarterly Earnings Results - MarketBeat
Edwards Lifesciences Lifts Outlook After Topping Expectations - Finimize
Edwards Lifesciences’ ALTERRA Study: A Potential Game-Changer in Heart Valve Treatment - TipRanks
Edwards Lifesciences (EW) Target Price Raised by Barclays to $99 - GuruFocus
Citigroup Raises Price Target for Edwards Lifesciences (EW) to $96 | EW Stock News - GuruFocus
Edwards Lifesciences (EW): Analyst Updates and Raised Price Targ - GuruFocus
Goldman Sachs Raises Price Target for Edwards Lifesciences (EW) to $104 | EW Stock News - GuruFocus
Canaccord Genuity Raises Edwards Lifesciences' Price Target to $84 From $81 - MarketScreener
Piper Sandler Raises Edwards Lifesciences (EW) Price Target to $95 | EW Stock News - GuruFocus
RBC Capital Raises Price Target for Edwards Lifesciences (EW) to $95.00 | EW Stock News - GuruFocus
Stifel Raises Edwards Lifesciences (EW) Price Target to $95 with Buy Rating | EW Stock News - GuruFocus
Evercore ISI Group Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $88 From $84 - MarketScreener
Citigroup Adjusts Price Target on Edwards Lifesciences to $96 From $95 - MarketScreener
Stifel Adjusts Price Target on Edwards Lifesciences to $95 From $85 - MarketScreener
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $95 From $88 - MarketScreener
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $92 From $88 - MarketScreener
TD Cowen Adjusts Price Target on Edwards Lifesciences to $90 From $84 - MarketScreener
Rothschild & Co Redburn Adjusts Price Target on Edwards Lifesciences to $93 From $85 - MarketScreener
Barclays Adjusts Price Target on Edwards Lifesciences to $99 From $95 - MarketScreener
Deutsche Bank Adjusts Price Target on Edwards Lifesciences to $100 From $94 - MarketScreener
JPMorgan Adjusts Price Target on Edwards Lifesciences to $90 From $85 - MarketScreener
Jefferies Adjusts Price Target on Edwards Lifesciences to $102 From $98 - MarketScreener
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $104 From $94 - MarketScreener
Edwards Lifesciences (NYSE:EW) Rating Increased to Buy at Jefferies Financial Group - MarketBeat
자본화:
|
볼륨(24시간):